Results for tag: "Trabectedin"

Trabectedin is an oncology drug used to treat certain types of cancer, including soft tissue sarcoma, ovarian cancer, and liposarcoma. It is a type of chemotherapy drug, and works by interfering with the growth and spread of cancer cells. Trabectedin is administered intravenously, and is usually given in combination with other drugs. It is generally used in patients who have already received other treatments, such as surgery or radiation therapy. Trabectedin has been approved for use in several countries, including the United States, Europe, and Japan. It is also being studied in clinical trials for other types of cancer, such as breast cancer and lung cancer. The trabectedin market is highly competitive, with several companies offering the drug. These include Johnson & Johnson, Merck, Pfizer, and Bristol-Myers Squibb. Other companies involved in the market include Eisai, Teva Pharmaceuticals, and AstraZeneca. Show Less Read more